300705 九典制药
交易中 01-10 13:24:15
资讯
新帖
简况
一周复盘 | 九典制药本周累计下跌25.01%,化学制药板块下跌5.27%
金融界 · 01-05
一周复盘 | 九典制药本周累计下跌25.01%,化学制药板块下跌5.27%
九典制药:时间投资投资者于1月3日调研我司
证券之星 · 01-04
九典制药:时间投资投资者于1月3日调研我司
九典制药:12月30日接受机构调研,东方证券、鹏扬基金等多家机构参与
证券之星 · 01-02
九典制药:12月30日接受机构调研,东方证券、鹏扬基金等多家机构参与
12月31日九典制药跌10.12%,华安聚优精选混合基金重仓该股
证券之星 · 2024-12-31
12月31日九典制药跌10.12%,华安聚优精选混合基金重仓该股
12月30日九典制药跌11.75%,华安聚优精选混合基金重仓该股
证券之星 · 2024-12-30
12月30日九典制药跌11.75%,华安聚优精选混合基金重仓该股
股价大跌,九典制药回应:市场有反馈万高药业氟比洛芬凝胶贴膏获上市申请受理,可能引起了波动
格隆汇 · 2024-12-30
股价大跌,九典制药回应:市场有反馈万高药业氟比洛芬凝胶贴膏获上市申请受理,可能引起了波动
股价放量大跌,九典制药:万高药业氟比洛芬凝胶贴膏获上市申请受理对公司没影响
21世纪经济报道 · 2024-12-30
股价放量大跌,九典制药:万高药业氟比洛芬凝胶贴膏获上市申请受理对公司没影响
盘中下挫18%,化药贴膏一哥九典制药股价闪崩真相
市场资讯 · 2024-12-30
盘中下挫18%,化药贴膏一哥九典制药股价闪崩真相
九典制药股价大跌超17%,原因为何
第一财经 · 2024-12-30
九典制药股价大跌超17%,原因为何
股价大跌,九典制药回应:市场有反馈万高药业氟比洛芬凝胶贴膏获上市申请受理,可能引起了波动
美港电讯 · 2024-12-30
股价大跌,九典制药回应:市场有反馈万高药业氟比洛芬凝胶贴膏获上市申请受理,可能引起了波动
九典制药新提交“典诺邦”等2件商标注册申请
证券之星 · 2024-12-29
九典制药新提交“典诺邦”等2件商标注册申请
九典制药新提交“典诺康”、“久跃”等8件商标注册申请
证券之星 · 2024-12-26
九典制药新提交“典诺康”、“久跃”等8件商标注册申请
九典制药:华源证券、工银瑞信等多家机构于12月25日调研我司
证券之星 · 2024-12-25
九典制药:华源证券、工银瑞信等多家机构于12月25日调研我司
九典制药:国金证券、中庚基金等多家机构于12月20日调研我司
证券之星 · 2024-12-23
九典制药:国金证券、中庚基金等多家机构于12月20日调研我司
九典制药:鑫巢资本、申万宏源资管等多家机构于12月17日调研我司
证券之星 · 2024-12-18
九典制药:鑫巢资本、申万宏源资管等多家机构于12月17日调研我司
九典制药(300705.SZ)股东段立新减持公司股份超过1%
智通财经 · 2024-12-16
九典制药(300705.SZ)股东段立新减持公司股份超过1%
九典制药(300705)12月16日主力资金净卖出2091.82万元
证券之星 · 2024-12-16
九典制药(300705)12月16日主力资金净卖出2091.82万元
九典制药12月13日现10笔大宗交易 成交金额6727.57万元
新浪证券-红岸工作室 · 2024-12-13
九典制药12月13日现10笔大宗交易 成交金额6727.57万元
12月13日九典制药现10笔大宗交易 机构净买入5090.81万元
证券之星 · 2024-12-13
12月13日九典制药现10笔大宗交易 机构净买入5090.81万元
12月12日九典制药发生10笔大宗交易 成交金额4022.2万元
证券之星 · 2024-12-12
12月12日九典制药发生10笔大宗交易 成交金额4022.2万元
加载更多
公司概况
公司名称:
湖南九典制药股份有限公司
所属行业:
医药制造业
上市日期:
2017-10-10
主营业务:
湖南九典制药股份有限公司主营业务为医药产品的研发、生产和销售,产品主要包括药品制剂、原料药、药用辅料及CXO服务四大类别。公司是国家企业技术中心、国家高技术产业化示范工程企业、国家火炬计划重点高新技术企业、湖南省高新技术企业。公司设有药物研究院,其被认定为湖南省企业技术中心,公司建有博士后科研工作站、新型凝胶膏剂湖南省工程研究中心、湖南省呼吸道药物工程技术研究中心等创新平台。
发行价格:
10.37
{"stockData":{"symbol":"300705","market":"SZ","secType":"STK","nameCN":"九典制药","latestPrice":17.37,"timestamp":1736486655000,"preClose":16.76,"halted":0,"volume":29863731,"delay":0,"changeRate":0.0364,"floatShares":367000000,"shares":496000000,"eps":1.0239,"marketStatus":"交易中","change":0.61,"latestTime":"01-10 13:24:15","open":16.62,"high":17.8,"low":16.28,"amount":508000000,"amplitude":0.0907,"askPrice":17.37,"askSize":12,"bidPrice":17.36,"bidSize":118,"shortable":0,"etf":0,"ttmEps":1.0239,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1736492400000},"marketStatusCode":2,"adr":0,"adjPreClose":16.76,"symbolType":"stock","openAndCloseTimeList":[[1736472600000,1736479800000],[1736485200000,1736492400000]],"highLimit":18.44,"lowLimit":15.08,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":496194320,"isCdr":false,"pbRate":3.6,"roa":"--","peRate":16.964547,"roe":"20.46%","epsLYR":1.07,"committee":0.228808,"marketValue":8619000000,"turnoverRate":0.0814,"status":0,"floatMarketCap":6370000000},"requestUrl":"/m/hq/s/300705","defaultTab":"news","newsList":[{"id":"2501649984","title":"一周复盘 | 九典制药本周累计下跌25.01%,化学制药板块下跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501649984","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501649984?lang=zh_cn&edition=full","pubTime":"2025-01-05 10:54","pubTimestamp":1736045699,"startTime":"0","endTime":"0","summary":"九典制药本周累计下跌25.01%,周总成交额30.15亿元,截至本周收盘,九典制药股价为16.97元。市场认为,九典制药股价大跌背后,或跟江苏万高药业股份有限公司提交的氟比洛芬凝胶贴膏上市申请于12月27日获受理这一消息有关,该药属于4类仿制药。股价大跌逾17%,九典制药回应:市场有反馈万高药业氟比洛芬凝胶贴膏获上市申请受理,可能引起了波动九典制药早盘大跌超17%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/05105447135581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK1574","BK1191","01477","300705"],"gpt_icon":0},{"id":"2500217775","title":"九典制药:时间投资投资者于1月3日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2500217775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500217775?lang=zh_cn&edition=full","pubTime":"2025-01-04 10:31","pubTimestamp":1735957881,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年1月3日九典制药发布公告称时间投资机构投资者代表共1人于2025年1月3日调研我司。九典制药2024年三季报显示,公司主营收入21.46亿元,同比上升13.36%;归母净利润4.5亿元,同比上升45.08%;扣非净利润4.18亿元,同比上升44.82%;其中2024年第三季度,公司单季度主营收入7.8亿元,同比上升15.47%;单季度归母净利润1.66亿元,同比上升47.38%;单季度扣非净利润1.63亿元,同比上升47.37%;负债率26.47%,投资收益254.11万元,财务费用1156.8万元,毛利率73.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010400008422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2500096319","title":"九典制药:12月30日接受机构调研,东方证券、鹏扬基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2500096319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500096319?lang=zh_cn&edition=full","pubTime":"2025-01-02 09:02","pubTimestamp":1735779760,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年12月31日九典制药发布公告称公司于2024年12月30日接受机构调研,东方证券、鹏扬基金、华福证券、平安证券、华源证券、华夏基金、华安基金、安信基金、融通基金、博时基金参与。该股最近90天内共有12家机构给出评级,买入评级10家,增持评级2家;过去90天内机构目标均价为26.53。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010200002254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1147","BK0028","BK0239","03958","BK0276","BK0012","BK1564","600958","BK0183","300705","BK0188"],"gpt_icon":0},{"id":"2495638986","title":"12月31日九典制药跌10.12%,华安聚优精选混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2495638986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495638986?lang=zh_cn&edition=full","pubTime":"2024-12-31 16:27","pubTimestamp":1735633678,"startTime":"0","endTime":"0","summary":"证券之星消息,12月31日九典制药跌10.12%创60日新低,收盘报17.95元,换手率11.78%,成交量43.22万手,成交额7.91亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共60家,其中持有数量最多的公募基金为华安聚优精选混合。华安聚优精选混合目前规模为44.37亿元,最新净值0.6132,较上一交易日下跌0.36%,近一年下跌4.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123100027252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2495597463","title":"12月30日九典制药跌11.75%,华安聚优精选混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2495597463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495597463?lang=zh_cn&edition=full","pubTime":"2024-12-30 16:15","pubTimestamp":1735546556,"startTime":"0","endTime":"0","summary":"证券之星消息,12月30日九典制药跌11.75%创60日新低,收盘报19.97元,换手率16.2%,成交量59.41万手,成交额11.6亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共60家,其中持有数量最多的公募基金为华安聚优精选混合。华安聚优精选混合目前规模为44.37亿元,最新净值0.6154,较上一交易日下跌0.36%,近一年下跌1.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123000020028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2495593018","title":"股价大跌,九典制药回应:市场有反馈万高药业氟比洛芬凝胶贴膏获上市申请受理,可能引起了波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2495593018","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495593018?lang=zh_cn&edition=full","pubTime":"2024-12-30 14:32","pubTimestamp":1735540344,"startTime":"0","endTime":"0","summary":"九典制药早盘大跌超17%。市场有反馈江苏万高药业有限公司氟比洛芬凝胶贴膏上市申请获受理,但是否获批还没结果,股价可能引起了波动。12月投资者关系管理信息显示,九典制药预计2025年将获批的氟比洛芬凝胶贴膏,预计2026年将获批外用制剂氟比洛芬贴剂。同时,该人士介绍,若后续上市,氟比洛芬凝胶贴膏也并非公司独家产品,北京泰德制药也有相关产品。公告显示,九典制药独家剂型产品为洛索洛芬钠凝胶贴膏。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/30143246932131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2495968165","title":"股价放量大跌,九典制药:万高药业氟比洛芬凝胶贴膏获上市申请受理对公司没影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2495968165","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495968165?lang=zh_cn&edition=full","pubTime":"2024-12-30 14:31","pubTimestamp":1735540260,"startTime":"0","endTime":"0","summary":"对于股价下跌,有关人士表示,公司经营一切正常。市场有反馈江苏万高药业有限公司氟比洛芬凝胶贴膏上市申请获受理,但是否获批还没结果,市场(股价)可能引起了波动。 12月25日的投资者关系管理信息显示,九典制药预计2025年将获批氟比洛芬凝胶贴膏,预计2026年将获批外用制剂氟比洛芬贴剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-30/doc-inecfrap2367644.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-30/doc-inecfrap2367644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2495591966","title":"盘中下挫18%,化药贴膏一哥九典制药股价闪崩真相","url":"https://stock-news.laohu8.com/highlight/detail?id=2495591966","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495591966?lang=zh_cn&edition=full","pubTime":"2024-12-30 14:28","pubTimestamp":1735540080,"startTime":"0","endTime":"0","summary":" 九典制药的闪崩绝非偶然,背后反映着,长期被市场低迷情绪所掩盖的,对他未来发展更深层次的担忧。 今日,九典制药盘中逼近跌停,跌幅一度接近19%,成交量创出历史新高。 九典制药此前披露,预计2025年将获批的氟比洛芬凝胶贴膏,预计2026年将获批外用制剂氟比洛芬贴剂。 那么,万高药业氟比洛芬凝胶贴膏上市获受理对九典制药有何影响?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-30/doc-inecfrap2373955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2495593316","title":"九典制药股价大跌超17%,原因为何","url":"https://stock-news.laohu8.com/highlight/detail?id=2495593316","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495593316?lang=zh_cn&edition=full","pubTime":"2024-12-30 14:10","pubTimestamp":1735539000,"startTime":"0","endTime":"0","summary":"市场认为,九典制药股价大跌背后,或跟江苏万高药业股份有限公司提交的氟比洛芬凝胶贴膏上市申请于12月27日获受理这一消息有关,该药属于4类仿制药。截至目前,九典制药尚未有氟比洛芬凝胶贴膏产品上市,但在洛索洛芬钠凝胶贴膏领域,公司则属于这个细分赛道的“隐形冠军”。作为九典制药旗下疼痛类贴膏类大品种,洛索洛芬钠凝胶贴膏2022年和2023年在全国医院销售(全终端)市场份额占有率均高达100%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-12-30/doc-inecfkuv4599349.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-30/doc-inecfkuv4599349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2495619045","title":"股价大跌,九典制药回应:市场有反馈万高药业氟比洛芬凝胶贴膏获上市申请受理,可能引起了波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2495619045","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495619045?lang=zh_cn&edition=full","pubTime":"2024-12-30 12:07","pubTimestamp":1735531653,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["01477","BK0239","BK1574","300705","BK1191"],"gpt_icon":0},{"id":"2495323138","title":"九典制药新提交“典诺邦”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2495323138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495323138?lang=zh_cn&edition=full","pubTime":"2024-12-29 04:44","pubTimestamp":1735418668,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日湖南九典制药股份有限公司新提交“典诺邦”等2件商标注册申请。商标申请详情如下:今年以来湖南九典制药股份有限公司新申请注册商标154件,截止目前公司共持有注册商标578件,另有264件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122900000094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300705"],"gpt_icon":0},{"id":"2494072672","title":"九典制药新提交“典诺康”、“久跃”等8件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2494072672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494072672?lang=zh_cn&edition=full","pubTime":"2024-12-26 05:44","pubTimestamp":1735163078,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日湖南九典制药股份有限公司新提交“典诺康”、“久跃”等8件商标注册申请。商标申请详情如下:今年以来湖南九典制药股份有限公司新申请注册商标139件,截止目前公司共持有注册商标578件,另有249件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122600002640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2494046790","title":"九典制药:华源证券、工银瑞信等多家机构于12月25日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2494046790","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494046790?lang=zh_cn&edition=full","pubTime":"2024-12-25 19:03","pubTimestamp":1735124588,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年12月25日九典制药发布公告称华源证券、工银瑞信于2024年12月25日调研我司。该股最近90天内共有11家机构给出评级,买入评级9家,增持评级2家;过去90天内机构目标均价为26.53。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122500030596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","161027","300705"],"gpt_icon":0},{"id":"2493745882","title":"九典制药:国金证券、中庚基金等多家机构于12月20日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2493745882","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493745882?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:03","pubTimestamp":1734915804,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年12月20日九典制药发布公告称国金证券、中庚基金、兴全基金于2024年12月20日调研我司。九典制药2024年三季报显示,公司主营收入21.46亿元,同比上升13.36%;归母净利润4.5亿元,同比上升45.08%;扣非净利润4.18亿元,同比上升44.82%;其中2024年第三季度,公司单季度主营收入7.8亿元,同比上升15.47%;单季度归母净利润1.66亿元,同比上升47.38%;单季度扣非净利润1.63亿元,同比上升47.37%;负债率26.47%,投资收益254.11万元,财务费用1156.8万元,毛利率73.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122300001622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0183","BK0276","BK0201","600109","BK0188","300705","BK0012"],"gpt_icon":0},{"id":"2492404119","title":"九典制药:鑫巢资本、申万宏源资管等多家机构于12月17日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492404119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492404119?lang=zh_cn&edition=full","pubTime":"2024-12-18 11:04","pubTimestamp":1734491062,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年12月17日九典制药发布公告称鑫巢资本、申万宏源资管、Alpines Capital、博时基金、中金证券、远信投资、宏道投资、国信证券、翼品资产于2024年12月17日调研我司。第三季度公司贴膏剂销售总额为 4.62 亿元,同比增长15.57%,销售数量同比增长 80.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800015360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1147","BK0028","BK0239","BK0183","BK0276","BK0012","300705","BK1564","06806","000166","BK0188"],"gpt_icon":0},{"id":"2491266714","title":"九典制药(300705.SZ)股东段立新减持公司股份超过1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491266714","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491266714?lang=zh_cn&edition=full","pubTime":"2024-12-16 20:13","pubTimestamp":1734351184,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九典制药(300705.SZ)发布公告,公司于近日收到股东段立新女士出具的《股份减持计划实施进展告知函》,其于2023年2月21日至2024年12月13日期间减持公司股份数量超过1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2491265351","title":"九典制药(300705)12月16日主力资金净卖出2091.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491265351","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491265351?lang=zh_cn&edition=full","pubTime":"2024-12-16 15:29","pubTimestamp":1734334189,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月16日收盘,九典制药报收于24.98元,下跌4.69%,换手率2.06%,成交量7.51万手,成交额1.88亿元。12月16日的资金流向数据方面,主力资金净流出2091.82万元,占总成交额11.1%,游资资金净流入466.5万元,占总成交额2.48%,散户资金净流入1625.32万元,占总成交额8.63%。九典制药主营业务:医药产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600014165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300705","BK0239"],"gpt_icon":0},{"id":"2491349055","title":"九典制药12月13日现10笔大宗交易 成交金额6727.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491349055","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491349055?lang=zh_cn&edition=full","pubTime":"2024-12-13 17:01","pubTimestamp":1734080460,"startTime":"0","endTime":"0","summary":" 12月13日,九典制药收涨0.19%,收盘价为26.21元,发生10笔大宗交易,合计成交量279.5万股,成交金额6727.57万元。 第10笔成交价格为24.07元,成交25.00万股,成交金额601.75万元,溢价率为-8.16%,买方营业部为机构专用,卖方营业部为西南证券股份有限公司浏阳环府路证券营业部。 进一步统计,近3个月内该股累计发生20笔大宗交易,合计成交金额为1.07亿元。该股近5个交易日累计上涨1.63%,主力资金合计净流出1332.37万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-13/doc-incziefr2753668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300705"],"gpt_icon":0},{"id":"2491468423","title":"12月13日九典制药现10笔大宗交易 机构净买入5090.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491468423","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491468423?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:49","pubTimestamp":1734079761,"startTime":"0","endTime":"0","summary":"证券之星消息,12月13日九典制药发生大宗交易,交易数据如下:近三个月该股共发生20笔大宗交易,合计成交4.5万手,折价成交20笔。该股近期无解禁股上市。截至2024年12月13日收盘,九典制药(300705)报收于26.21元,上涨0.19%,换手率2.11%,成交量7.71万手,成交额2.03亿元。该股最近90天内共有11家机构给出评级,买入评级9家,增持评级2家;过去90天内机构目标均价为26.53。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300028945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300705"],"gpt_icon":0},{"id":"2490748728","title":"12月12日九典制药发生10笔大宗交易 成交金额4022.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490748728","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490748728?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:48","pubTimestamp":1733993319,"startTime":"0","endTime":"0","summary":"证券之星消息,12月12日九典制药发生大宗交易,交易数据如下:近三个月该股共发生10笔大宗交易,合计成交1.7万手,折价成交10笔。该股近期无解禁股上市。截至2024年12月12日收盘,九典制药(300705)报收于26.16元,上涨1.71%,换手率1.21%,成交量4.42万手,成交额1.15亿元。该股最近90天内共有11家机构给出评级,买入评级9家,增持评级2家;过去90天内机构目标均价为26.53。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200026648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300705"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-10-10","address":"湖南省长沙市浏阳市经济技术开发区健康大道1号","stockEarnings":[{"period":"1week","weight":-0.0227},{"period":"1month","weight":-0.3539},{"period":"3month","weight":-0.2892},{"period":"6month","weight":-0.3569},{"period":"1year","weight":-0.2515},{"period":"ytd","weight":-0.0663}],"companyName":"湖南九典制药股份有限公司","boardCode":"AI0027","perCapita":"31303股","boardName":"医药制造业","registeredCapital":"49619万元","compareEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.002},{"period":"6month","weight":0.0808},{"period":"1year","weight":0.116},{"period":"ytd","weight":-0.0419}],"survey":" 湖南九典制药股份有限公司主营业务为医药产品的研发、生产和销售,产品主要包括药品制剂、原料药、药用辅料及CXO服务四大类别。公司是国家企业技术中心、国家高技术产业化示范工程企业、国家火炬计划重点高新技术企业、湖南省高新技术企业。公司设有药物研究院,其被认定为湖南省企业技术中心,公司建有博士后科研工作站、新型凝胶膏剂湖南省工程研究中心、湖南省呼吸道药物工程技术研究中心等创新平台。","serverTime":1736486659675,"listedPrice":10.37,"stockholders":"11716人(较上一季度增加23.57%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九典制药(300705)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九典制药(300705)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九典制药,300705,九典制药股票,九典制药股票老虎,九典制药股票老虎国际,九典制药行情,九典制药股票行情,九典制药股价,九典制药股市,九典制药股票价格,九典制药股票交易,九典制药股票购买,九典制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九典制药(300705)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九典制药(300705)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}